We can all look forward to an announcement in March next year where ATH will announce that they look forward to initiating the trial in the second quarter of calendar year 2022.
Pardon my pessimism but it’s a side effect of being a long term shareholder.
Ann: Expanded ATH434 Phase 2 Clinical Development Program, page-7
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $26.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.288K | 257.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 102 | 97593686 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 31179254 | 15 |
View Market Depth
| Last trade - 09.59am 26/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |